Miach Orthopedics names Arjun Ishwar as VP of sales and marketing

Miach Orthopedics today announced it appointed Arjun Ishwar as VP of sales and marketing.

Iswar brings experience in corporate strategic planning and execution, sales and marketing leadership and commercialization to the Westborough, Massachusetts-based company. He will lead Miach’s commercialization efforts for the Bridge-Enhanced ACL Restoration (BEAR) Implant, which launched in the U.S. in fall 2021.

“Arjun is a proven leader in the medical device field and has a strong track record of developing and implementing business strategies for medical technologies that improve patients’ lives. Lending his expertise to the BEAR Implant is a natural fit,” said President and CEO Patrick McBrayer. “Our experience working together to drive adoption of tissue regeneration products will be invaluable as we continue the commercial rollout of the BEAR Implant in the U.S.”

Most recently, Ishwar was chief commercial officer of MY01. He has also held varying roles…

Read more
  • 0

Miach Orthopaedics makes ACL tear implant commercially available in U.S.

Miach Orthopaedics announced today that it made the BEAR implant for treating anterior cruciate ligament (ACL) tears commercially available in the U.S.

Westborough, Massachusetts-based Miach designed the BEAR (Bridge-Enhanced ACL repair) implant to enable the healing of a patient’s torn ACL, shifting from the current standard of care that includes reconstruction that replaces the ACL with a graft.

According to a news release, the BEAR implant also received a Popular Science Best of What’s New Award for its representation of a significant step forward in health.

The BEAR implant restores ACL quality and size similar to the non-injured ACL to provide a faster recovery of muscle strength and better patient satisfaction around returns to sports. By eliminating the need for a graft, BEAR allows for patients to avoid needing a second wound site to heal and alleviates worries about donor graft quality or risk of disease.

Dr. Jonathan L. Glash…

Read more
  • 0

Miach Orthopedics names new CFO, board member

Miach Orthopedics this week announced that it has appointed Christopher Joyce as VP and chief financial officer and has appointed Kevin Sidow to the board of directors.

Joyce will be responsible for leading the financial operations. He has more than 30 years of experience in finance and most recently served as consulting CFO for several biotech and medical device startups. Prior to that, he was on the founding teams as a CFO of FRX Polymers and Elemé Medical and Percardia.

Sidow is also a medical device industry veteran with more than 35 years of experience in orthopedics. He has served as president and CEO for Moximed and St. Francis Medical Technologies and held numerous leadership roles at Johnson & Johnson’s Depuy.

“We are thrilled to welcome Chris, who has an impressive background in managing finance and operations for medical device startups, and Kevin, a highly accomplished and well-respected leader in bringing orthopedic products to mar…

Read more
  • 0